Jf. Tanti et al., OKADAIC ACID STIMULATES IGF-II RECEPTOR TRANSLOCATION AND INHIBITS INSULIN ACTION IN ADIPOCYTES, The American journal of physiology, 264(6), 1993, pp. 868-873
Okadaic acid, an inhibitor of protein phosphatases 2A and 1, stimulate
s glucose transport in muscle and fat cells, suggesting that serine/th
reonine phosphorylation steps are involved in the translocation of glu
cose transporters. Here we have investigated whether such phosphorylat
ion events could also participate in another membrane-associated insul
in-stimulated process: insulin-like growth factor II (IGF-II) receptor
translocation in adipocytes. Maximally effective concentrations of in
sulin and okadaic acid stimulated deoxyglucose uptake by 5.5- and 2.5-
fold, respectively, whereas IGF-II binding was increased 3.5-fold and
1.5-fold. Subcellular fractionation indicated that the okadaic acid-in
duced stimulation of IGF-II binding resulted from an increase in the n
umber of IGF-II receptors in the plasma membrane with a concomitant di
sappearance from the low-density microsomal fraction. These changes oc
curred in parallel to those observed for the glucose transporter GLUT-
4. Both insulin-stimulated glucose transport and IGF-II binding were p
revented when cells were pretreated with okadaic acid. To understand t
he mechanism of this inhibitory effect, insulin receptor autophosphory
lation and the tyrosine phosphorylation of endogenous proteins were st
udied. Insulin induced the tyrosine phosphorylation of its receptor be
ta-subunit and of proteins at 120 and 185 kDa, whereas okadaic acid al
one had no effect. When okadaic acid and insulin were added together,
the beta-subunit autophosphorylation was similar to that observed with
insulin alone, but the tyrosine phosphorylation of substrates was pre
vented. Taken together, our data suggest that, in adipocytes, serine/t
hreonine phosphorylation events mimicked by okadaic acid are required
for the translocation of IGF-II receptors and glucose transporters. Fi
nally, okadaic acid would block insulin effect by preventing the tyros
ine phosphorylation of insulin receptor cellular substrates.